These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 27562401)

  • 1. Impact of proton pump inhibitor treatment on pancreatic beta-cell area and beta-cell proliferation in humans.
    Breuer TG; Borker L; Quast DR; Tannapfel A; Schmidt WE; Uhl W; Meier JJ
    Eur J Endocrinol; 2016 Nov; 175(5):467-76. PubMed ID: 27562401
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combination therapy with a dipeptidyl peptidase-4 inhibitor and a proton pump inhibitor induces β-cell neogenesis from adult human pancreatic duct cells implanted in immunodeficient mice.
    Suarez-Pinzon WL; Rabinovitch A
    Cell Transplant; 2011; 20(9):1343-9. PubMed ID: 21396168
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Effect of Proton Pump Inhibitors on Glycemic Control in Patients with Type 2 Diabetes.
    Villegas K; Meier JL; Long M; Lopez J; Swislocki A
    Metab Syndr Relat Disord; 2019 May; 17(4):192-196. PubMed ID: 30730235
    [No Abstract]   [Full Text] [Related]  

  • 4. Predominance of β-cell neogenesis rather than replication in humans with an impaired glucose tolerance and newly diagnosed diabetes.
    Yoneda S; Uno S; Iwahashi H; Fujita Y; Yoshikawa A; Kozawa J; Okita K; Takiuchi D; Eguchi H; Nagano H; Imagawa A; Shimomura I
    J Clin Endocrinol Metab; 2013 May; 98(5):2053-61. PubMed ID: 23539729
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pantoprazole may improve beta cell function and diabetes mellitus.
    Inci F; Atmaca M; Ozturk M; Yildiz S; Koceroglu R; Sekeroglu R; Ipekci SH; Kebapcilar L
    J Endocrinol Invest; 2014 May; 37(5):449-54. PubMed ID: 24682913
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proton pump inhibitors: impact on glucose metabolism.
    Boj-Carceller D
    Endocrine; 2013 Feb; 43(1):22-32. PubMed ID: 22886351
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ectopic fat storage in the pancreas, liver, and abdominal fat depots: impact on β-cell function in individuals with impaired glucose metabolism.
    van der Zijl NJ; Goossens GH; Moors CC; van Raalte DH; Muskiet MH; Pouwels PJ; Blaak EE; Diamant M
    J Clin Endocrinol Metab; 2011 Feb; 96(2):459-67. PubMed ID: 21084401
    [TBL] [Abstract][Full Text] [Related]  

  • 8. No Association of Proton Pump Inhibitor Use with Fasting or Postload Glycaemia in Patients with Cardiovascular Disease: A Cross-Sectional Retrospective Study.
    Kruszelnicka O; Kuźma M; Pena IZ; Perera IB; Chyrchel B; Wieczorek-Surdacka E; Surdacki A
    Int J Med Sci; 2017; 14(10):1015-1021. PubMed ID: 28924374
    [No Abstract]   [Full Text] [Related]  

  • 9. Treatment with a proton pump inhibitor improves glycaemic control in Psammomys obesus, a model of type 2 diabetes.
    Bödvarsdóttir TB; Hove KD; Gotfredsen CF; Pridal L; Vaag A; Karlsen AE; Petersen JS
    Diabetologia; 2010 Oct; 53(10):2220-3. PubMed ID: 20585936
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A prospective evaluation of the effect of chronic proton pump inhibitor use on plasma biomarker levels in humans.
    Raines D; Chester M; Diebold AE; Mamikunian P; Anthony CT; Mamikunian G; Woltering EA
    Pancreas; 2012 May; 41(4):508-11. PubMed ID: 22460728
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proton pump inhibitor therapy associated with lower glycosylated hemoglobin levels in type 2 diabetes.
    Crouch MA; Mefford IN; Wade EU
    J Am Board Fam Med; 2012; 25(1):50-4. PubMed ID: 22218624
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pantoprazole improves glycemic control in type 2 diabetes: a randomized, double-blind, placebo-controlled trial.
    Singh PK; Hota D; Dutta P; Sachdeva N; Chakrabarti A; Srinivasan A; Singh I; Bhansali A
    J Clin Endocrinol Metab; 2012 Nov; 97(11):E2105-8. PubMed ID: 22904177
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fate of the beta-cell in the pathophysiology of type 2 diabetes.
    Campbell RK
    J Am Pharm Assoc (2003); 2009; 49 Suppl 1():S10-5. PubMed ID: 19801360
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term liraglutide treatment is associated with increased insulin content and secretion in β-cells, and a loss of α-cells in ZDF rats.
    Schwasinger-Schmidt T; Robbins DC; Williams SJ; Novikova L; Stehno-Bittel L
    Pharmacol Res; 2013 Oct; 76():58-66. PubMed ID: 23891763
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Liraglutide improves pancreatic Beta cell mass and function in alloxan-induced diabetic mice.
    Tamura K; Minami K; Kudo M; Iemoto K; Takahashi H; Seino S
    PLoS One; 2015; 10(5):e0126003. PubMed ID: 25938469
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of proton pump inhibitors on glycated hemoglobin levels in patients with type 2 diabetes mellitus.
    Han N; Oh M; Park SM; Kim YJ; Lee EJ; Kim TK; Kim TN; Kwon MJ; Kim MK; Lee SH; Rhee BD; Park JH
    Can J Diabetes; 2015 Feb; 39(1):24-8. PubMed ID: 25305802
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protection of pancreatic beta-cells: is it feasible?
    Bonora E
    Nutr Metab Cardiovasc Dis; 2008 Jan; 18(1):74-83. PubMed ID: 18096375
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Baseline osteocalcin levels and incident diabetes in a 3-year prospective study of high-risk individuals.
    Liatis S; Sfikakis PP; Tsiakou A; Stathi C; Terpos E; Katsilambros N; Makrilakis K
    Diabetes Metab; 2014 Jun; 40(3):198-203. PubMed ID: 24529960
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of Silymarin in Pdx-1 expression and the proliferation of pancreatic β-cells in a pancreatectomy model.
    Soto C; Raya L; Juárez J; Pérez J; González I
    Phytomedicine; 2014 Feb; 21(3):233-9. PubMed ID: 24176839
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatic role in an early glucose-lowering effect by a novel dipeptidyl peptidase 4 inhibitor, evogliptin, in a rodent model of type 2 diabetes.
    Kim TH; Kim MK; Cheong YH; Chae YN; Lee Y; Ka SO; Jung IH; Shin CY; Bae EJ; Son MH
    Eur J Pharmacol; 2016 Jan; 771():65-76. PubMed ID: 26621343
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.